Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins

Blood (2019) 134 (Supplement_1): 1200.

https://doi.org/10.1182/blood-2019-132005

Published: 2019

Journal Articles

Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation

Blood (2018) 132 (Supplement 1): 4346.

https://doi.org/10.1182/blood-2018-99-119712

Published: 2018

Journal Articles

Exosome Polyphosphate Mediates the Activation of FXII By Cancer Cell-Derived Exosomes

Dewen You, PhD, Suman Kundu, MBA, Alvin H. Schmaier, MD, Alok A. Khorana, MD, Keith R. McCrae, MD

Blood (2018) 132 (Supplement 1): 3800.

https://doi.org/10.1182/blood-2018-99-117308

Published: 2018

Journal Articles

Modulation of TET2 Activity with Ascorbic Acid in Myeloid Neoplasia: Diagnostic and Therapeutic Implications

Edward F Greenberg, MD, Cassandra M. Hirsch, BS, Shi Chen, Xiaochen Liiu, Babal K Jha, PhD, Valeria Visconte, PhD, Dewen You, PhD, Bartlomiej P. Przychodzen, MSc, Thomas Laframboise, PhD, Hideki Makishima, MD PhD, Aziz Nazha, MD, Mingjiang Xu, MDPhD, Daniel Gackowski, PhD, Mridul Mukherji, D.Phil., Mikkael A. Sekeres, MD MS, Ryszard Ólinski, Professor, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 1205.

https://doi.org/10.1182/blood.V130.Suppl_1.1205.1205

Published: 2017

Journal Articles

Comparison of FXII Activation in Human Plasma By Extracellular Vesicles from Cancer Cells Versus Non-Transformed Cells

Dewen You, PhD, Victor Chatterjee, MD, Suman Kundu, MBA, Mohamed Samour, MBBS, Alvin H. Schmaier, MD, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 3705.

https://doi.org/10.1182/blood.V130.Suppl_1.3705.3705

Published: 2017

Journal Articles

TET2 and MSH6: A Novel Role for MMR in the Pathogenesis of Myeloid Malignancies

Edward F Greenberg, MD, Cassandra M. Hirsch, BS, Feng Pan, PhD, Babal K Jha, PhD, Yihong Guan, PhD, Valeria Visconte, PhD, Dewen You, PhD, Guangbo Qu, PhD, Amy Graham, Bartlomiej P. Przychodzen, MSc, Thomas Laframboise, PhD, Hideki Makishima, MD PhD, Daniel Gackowski, PhD, Ryszard Ólinski, Professor, Yu-Wei Cheng, PhD, Mikkael A. Sekeres, MD MS, Mingjiang Xu, MDPhD, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 1668.

https://doi.org/10.1182/blood.V130.Suppl_1.1668.1668

Published: 2017

Journal Articles

A Novel Immunoblot Assay to Detect Contact Activation in Patients with Cancer

Dewen You, PhD, Victor Chatterjee, MD, Mohamed Samour, MBBS, Suman Kundu, MBA, Alvin H. Schmaier, MD, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2385.

https://doi.org/10.1182/blood.V130.Suppl_1.2385.2385

Published: 2017

Journal Articles

Cancer Cell-Derived Extracellular Vesicles Are Prothrombotic in an in-Vitro Vessel Model

Victor Chatterjee, MD, Mohamed Samour, MBBS, Dewen You, PhD, Suman Kundu, MBA, Alok A. Khorana, MD, Keith McCrae, MD

Blood (2017) 130 (Supplement 1): 2308.

https://doi.org/10.1182/blood.V130.Suppl_1.2308.2308

Published: 2017

Journal Articles

U2AF1 Mutations in S34 and Q157 Create Distinct Molecular and Clinical Contexts

Vera Adema, PhD, Cassandra M. Hirsch, BSc, Bartlomiej P Przychodzen, MSc, Aziz Nazha, MD, Teodora Kuzmanovic, Eiju Negoro, MD, PhD, Dewen You, PhD, Hideki Makishima, MD PhD FACP., Michael J. Clemente, M.S., Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS, Valeria Visconte, PhD, Jaroslaw P. Maciejewski, MD, PhD, FACP

Blood (2016) 128 (22): 3155.

https://doi.org/10.1182/blood.V128.22.3155.3155

Published: 2016

Journal Articles

PHF6 Somatic Mutations and Their Functional Role in the Pathophysiology of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Bartlomiej P Przychodzen, MSc, Xiaorong Gu, PhD, Dewen You, PhD, Cassandra M. Hirsch, BSc, Michael J. Clemente, M.S., Mikkael A. Sekeres, MD MS, Aziz Nazha, MD, Hideki Makishima, MD PhD FACP., Jaroslaw P Maciejewski, MD PhD FACP

Blood (2016) 128 (22): 2736.

https://doi.org/10.1182/blood.V128.22.2736.2736

Published: 2016

Journal Articles

PHF6 - Somatic Mutations and Their Role in Pathophysiology of MDS and AML

Bartlomiej Przychodzen, MSc, Xiaorong Gu, PhD, Dewen You, PhD, Cassandra M. Hirsch, Michael J. Clemente, Aaron D. Viny, MD MS, Ross L. Levine, MD, Torsten Haferlach, Manja Maggendorfer, Mikkael A. Sekeres, MD MS, Hetty E. Carraway, MD MBA, Aziz Nazha, MD, Francis Enane, Jaroslaw P. Maciejewski, MD PhD

Blood (2015) 126 (23): 1259.

https://doi.org/10.1182/blood.V126.23.1259.1259

Published: 2015

Journal Articles

Sensitizing Acute Myeloid Leukemia Cells to Interferon-Induced Differentiation By Inhibiting RIP1/RIP3 Necroptotic Pathway

Blood (2014) 124 (21): 3752.

https://doi.org/10.1182/blood.V124.21.3752.3752

Published: 2014

Journal Articles

AML Cells Utilize TNF-Driven JNK Signaling As a Critical NF-κB-Independent Survival Signal

Andrew Volk, Jing Li, PhD, Junping Xin, PhD, Dewen You, PhD, Jun Zhang, PhD, Peter Breslin, PhD, Zejuan Li, MD, PhD, Wei Wei, Rachel Schmidt, Xinyu Li, MD, Zhou Zhang, PhD, Paul C Kuo, MD, Sucha Nand, MD, Jianke Zhang, PhD, Jianjun Chen, PhD, Jiwang Zhang, MD, PhD

Blood (2013) 122 (21): 2890.

https://doi.org/10.1182/blood.V122.21.2890.2890

Published: 2013

Journal Articles

Focal Adhesion Kinase Inactivation Reduces the Development of Acute Leukemia and Partially Rescues Hematopoietic Stem Cell Defects in Pten -Knockout Mice

Dewen You, PhD, Andrew Volk, Clare Sun, MD, Junping Xin, MD, PhD, Geunhyoung Ha, PhD, Chunliu Pan, PhD, Rachel Schmidt, Patience Oladeinde, Wei Wei, Subing Zhang, MD, Eun-Kyoung Breuer, PhD, Peter Breslin, PhD, Jiwang Zhang, MD, PhD

Blood (2012) 120 (21): 864.

https://doi.org/10.1182/blood.V120.21.864.864

Published: 2012

Journal Articles

Blockade of Mir-150 Maturation by MLL -Fusion/MYC/Lin-28 Is Required for MLL -Associated Leukemia

Blood (2012) 120 (21): 3499.

https://doi.org/10.1182/blood.V120.21.3499.3499

Published: 2012

Journal Articles

FLT3 Signaling Enhances Stemness in Murine MLL-AF9 Acute Myeloid Leukemia.

Clare Sun, MD, Christopher S. Seet, MD, Jun Zhang, PhD, Yechen Xiao, PhD, Dewen You, PhD, Jiwang Zhang, MD, PhD

Blood (2012) 120 (21): 2980.

https://doi.org/10.1182/blood.V120.21.2980.2980

Published: 2012

Journal Articles

Sensitizing Leukemic Cells to NF-κB Inhibitor Treatment by Repressing TNFα-Mediated, NF-κB-Independent Survival Signaling

Andrew Volk, Yechen Xiao, PhD, Junping Xin, PhD, Dewen You, PhD, Rachel Schmidt, Shubin Zhang, Wei Wei, Peter Breslin, PhD, Sucha Nand, MD, Jiwang Zhang, MD, PhD

Blood (2012) 120 (21): 1878.

https://doi.org/10.1182/blood.V120.21.1878.1878

Published: 2012

NARROW

TET2 Loss Accelerates Leukemogenesis By Disrupting Mismatch Repair Proteins

Modulation of TET2 Activity By Ascorbic Acid and Factors Affecting Lysine Acetylation

Exosome Polyphosphate Mediates the Activation of FXII By Cancer Cell-Derived Exosomes

Modulation of TET2 Activity with Ascorbic Acid in Myeloid Neoplasia: Diagnostic and Therapeutic Implications

Comparison of FXII Activation in Human Plasma By Extracellular Vesicles from Cancer Cells Versus Non-Transformed Cells

TET2 and MSH6: A Novel Role for MMR in the Pathogenesis of Myeloid Malignancies

A Novel Immunoblot Assay to Detect Contact Activation in Patients with Cancer

Cancer Cell-Derived Extracellular Vesicles Are Prothrombotic in an in-Vitro Vessel Model

U2AF1 Mutations in S34 and Q157 Create Distinct Molecular and Clinical Contexts

PHF6 Somatic Mutations and Their Functional Role in the Pathophysiology of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

PHF6 - Somatic Mutations and Their Role in Pathophysiology of MDS and AML

Sensitizing Acute Myeloid Leukemia Cells to Interferon-Induced Differentiation By Inhibiting RIP1/RIP3 Necroptotic Pathway

AML Cells Utilize TNF-Driven JNK Signaling As a Critical NF-κB-Independent Survival Signal

Focal Adhesion Kinase Inactivation Reduces the Development of Acute Leukemia and Partially Rescues Hematopoietic Stem Cell Defects in Pten -Knockout Mice

Blockade of Mir-150 Maturation by MLL -Fusion/MYC/Lin-28 Is Required for MLL -Associated Leukemia

FLT3 Signaling Enhances Stemness in Murine MLL-AF9 Acute Myeloid Leukemia.

Sensitizing Leukemic Cells to NF-κB Inhibitor Treatment by Repressing TNFα-Mediated, NF-κB-Independent Survival Signaling

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only